|
E2F6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.300000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.936830E-03 |
| Normal-vs-Stage2 |
1.807180E-01 |
| Normal-vs-Stage3 |
6.406500E-02 |
| Normal-vs-Stage4 |
2.374200E-02 |
| Stage1-vs-Stage2 |
4.673000E-01 |
| Stage1-vs-Stage3 |
2.934200E-01 |
| Stage1-vs-Stage4 |
7.609800E-01 |
| Stage2-vs-Stage3 |
9.801400E-01 |
| Stage2-vs-Stage4 |
6.722200E-01 |
| Stage3-vs-Stage4 |
5.605800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.800480E-02 |
| Normal-vs-AfricanAmerican |
4.804800E-04 |
| Normal-vs-Asian |
3.516200E-03 |
| Caucasian-vs-AfricanAmerican |
4.336800E-03 |
| Caucasian-vs-Asian |
8.461200E-03 |
| AfricanAmerican-vs-Asian |
4.200800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.889800E-02 |
| Normal-vs-Female |
1.037170E-04 |
| Male-vs-Female |
4.239000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.967000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.340200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.336520E-03 |
| Normal-vs-Age(81-100Yrs) |
1.351610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.384600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.172600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.156200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.626800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.616800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.670200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.925400E-01 |
| Normal-vs-Grade 2 |
3.161900E-04 |
| Normal-vs-Grade 3 |
6.212300E-02 |
| Normal-vs-Grade 4 |
1.468000E-01 |
| Grade 1-vs-Grade 2 |
9.212400E-01 |
| Grade 1-vs-Grade 3 |
5.606800E-01 |
| Grade 1-vs-Grade 4 |
5.375600E-01 |
| Grade 2-vs-Grade 3 |
3.150000E-02 |
| Grade 2-vs-Grade 4 |
5.846100E-02 |
| Grade 3-vs-Grade 4 |
8.842600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.33850000000469E-05 |
| Normal-vs-ccB subtype |
2.685600E-01 |
| ccA subtype-vs-ccB subtype |
1.424560E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.090200E-02 |
| Normal-vs-N1 |
1.160600E-01 |
| N0-vs-N1 |
3.488200E-01 |
|
|
